BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings results on Thursday. The medical equipment provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.06) by $0.03, Bloomberg Earnings reports. The company had revenue of $2.96 million during the quarter, compared to the consensus estimate of $2.60 million. BioLife Solutions had a negative return on equity of 64.98% and a negative net margin of 63.71%.

BioLife Solutions (BLFS) traded up $0.50 during trading on Friday, reaching $5.65. The company’s stock had a trading volume of 146,537 shares, compared to its average volume of 105,188. BioLife Solutions has a one year low of $1.50 and a one year high of $7.53.

WARNING: “BioLife Solutions, Inc. (BLFS) Announces Quarterly Earnings Results” was originally reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another site, it was copied illegally and republished in violation of US & international copyright & trademark law. The correct version of this piece can be accessed at https://www.thecerbatgem.com/2017/11/10/biolife-solutions-inc-blfs-announces-quarterly-earnings-results.html.

Separately, Maxim Group raised their price target on BioLife Solutions from $7.00 to $8.00 and gave the stock a “buy” rating in a research report on Friday.

About BioLife Solutions

BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.

Earnings History for BioLife Solutions (NASDAQ:BLFS)

Receive News & Stock Ratings for BioLife Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions Inc. and related stocks with our FREE daily email newsletter.